daemen college physical therapy, inc.

4380 main street
amherst, new york 14226

NYS Entity Status
ACTIVE

NYS Filing Date
APRIL 03, 2013

NYS DOS ID#
4382940

County
ERIE

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC NOT-FOR-PROFIT CORPORATION

Name History
2013 - DAEMEN COLLEGE PHYSICAL THERAPY, INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • When Affirmative Action Isn’t Enough
    By DANA GOLDSTEIN - Sunday Sep 17, 2017

    Black and Hispanic students are more underrepresented at top schools nationwide, despite affirmative action. Some schools, though, saw gains.

    Source: NYT > Home Page
  • Bots are becoming highly skilled assistants in physical therapy
    By Michal Prywata, Bionik Laboratories - Sunday Oct 15, 2017

    Within the last decade, we’ve seen incredible progress in the fields of robotics and artificial intelligence.  Innovators have been seeking out ways to meld man and machine and, in some areas, remove man altogether. In robotics, we’re seeing delivery drones, security robots, and more. In AI, chatbots, self-driving cars, and voice recognition have all made […]

    Source: VentureBeat
  • A New Way for Therapists to Get Inside Heads: Virtual Reality
    By CADE METZ - Sunday Jul 30, 2017

    Limbix, a start-up using Google headsets, helps psychologists expose patients to their anxieties in the safety of an office.

    Source: NYT > Home Page
  • The Rebuilding Years, Post-Sandy
    By THE NEW YORK TIMES and JONAH MARKOWITZ - Sunday Oct 29, 2017

    Those affected by Hurricane Sandy five years ago shared how the storm changed their lives physically, emotionally and financially, and how things have changed for the better since.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed